Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 2.625% 2/1
-
Unit price / market price
-
$0.9751
-
Total 13F principal
-
$121,963,000
-
Principal change
-
-$9,538,000
-
Total reported value
-
$124,806,000
-
Number of holders
-
13
-
Value change
-
-$3,671,443
-
Number of buys
-
4
-
Number of sells
-
7
Institutional Holders of COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1 as of Q4 2021
As of 31 Dec 2021 COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1 had 13 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $121,963,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, LAZARD ASSET MANAGEMENT LLC, STEELHEAD PARTNERS LLC, Linden Advisors LP, DeepCurrents Investment Group LLC, AQR Arbitrage LLC, MACQUARIE GROUP LTD, CALAMOS ADVISORS LLC, Verition Fund Management LLC, and MORGAN STANLEY.
This table shows 13 bond principal holders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.